Omnicell (OMCL) Financials

$29.61 +1.38 (+4.89%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$29.60 0.00 (-0.02%)

As of 05/27/2025 04:28 PM Eastern

Annual Income Statements for Omnicell

This table shows Omnicell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	13	-20	5.65	78	32	61	38	31	9.76	31	31
Consolidated Net Income / (Loss)	13	-20	5.65	78	32	61	38	31	9.76	31	31
Net Income / (Loss) Continuing Operations	13	-20	5.65	78	32	61	38	31	9.76	31	31
Total Pre-Tax Income	26	-20	-2.45	66	29	74	36	4.51	13	46	49
Total Operating Income	0.34	-35	-2.32	90	36	78	44	11	21	49	50
Total Gross Profit	471	497	589	555	413	437	372	319	317	248	234
Total Revenue	1,112	1,147	1,296	1,132	892	897	787	713	696	485	441
Operating Revenue	1,112	1,147	1,296	1,132	892	897	787	713	696	485	441
Total Cost of Revenue	641	650	707	577	479	460	415	394	379	237	207
Operating Cost of Revenue	641	650	707	577	479	460	415	394	379	237	207
Total Operating Expenses	471	532	591	465	378	359	328	307	296	199	184
Selling, General & Admin Expense	380	435	486	389	308	290	263	241	238	168	156
Research & Development Expense	90	97	105	76	70	69	65	66	58	35	28
Total Other Income / (Expense), net	25	15	-0.13	-24	-6.18	-4.42	-8.78	-6.63	-8.43	-2.39	-1.08
Other Income / (Expense), net	25	15	-0.13	-24	-6.18	-4.42	-8.78	-6.63	-8.43	-2.39	-1.08
Income Tax Expense	13	0.26	-8.10	-12	-2.85	13	-2.11	-26	3.22	15	18
Basic Earnings per Share	$0.27	($0.45)	$0.13	$1.79	$0.76	$1.48	$0.96	$0.81	$0.27	$0.86	$0.86
Weighted Average Basic Shares Outstanding	46.05M	45.21M	44.40M	43.48M	42.58M	41.46M	39.24M	37.48M	36.16M	35.86M	35.65M
Diluted Earnings per Share	$0.27	($0.45)	$0.12	$1.62	$0.74	$1.43	$0.93	$0.79	$0.26	$0.84	$0.83
Weighted Average Diluted Shares Outstanding	46.26M	45.21M	45.89M	47.94M	43.74M	42.94M	40.56M	38.71M	36.86M	36.72M	36.62M
Weighted Average Basic & Diluted Shares Outstanding	46.76M	45.92M	44.99M	44.42M	43.04M	42.47M	39.30M	37.70M	30.20M	35.80M	35.50M

This table shows Omnicell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-7.02	16	8.63	3.74	-16	-14	5.55	3.45	-15	-28	17
Consolidated Net Income / (Loss)	-7.02	16	8.63	3.74	-16	-14	5.55	3.45	-15	-28	17
Net Income / (Loss) Continuing Operations	-7.02	16	8.63	3.74	-16	-14	5.55	3.45	-15	-28	17
Total Pre-Tax Income	-9.53	24	12	8.20	-18	-19	7.38	12	-21	-36	17
Total Operating Income	-12	12	6.56	3.22	-22	-23	3.71	7.75	-23	-38	18
Total Gross Profit	111	142	122	114	93	105	132	134	125	122	159
Total Revenue	270	307	282	277	246	259	299	299	291	298	348
Operating Revenue	270	307	282	277	246	259	299	299	291	298	348
Total Cost of Revenue	159	165	160	162	154	153	167	165	166	176	189
Operating Cost of Revenue	159	165	160	162	154	153	167	165	166	176	189
Total Operating Expenses	123	129	116	111	114	129	128	127	148	160	141
Selling, General & Admin Expense	102	103	94	90	92	102	104	104	125	132	115
Research & Development Expense	21	26	21	21	22	27	24	23	23	28	25
Total Other Income / (Expense), net	2.09	11	5.06	4.97	4.02	4.85	3.67	4.46	1.78	2.84	-1.15
Other Income / (Expense), net	2.09	11	5.06	4.97	4.02	4.85	3.67	4.46	1.78	2.84	-1.15
Income Tax Expense	-2.51	7.76	3.00	4.46	-2.16	-4.14	1.83	8.76	-6.18	-7.11	0.54
Basic Earnings per Share	($0.15)	$0.34	$0.19	$0.08	($0.34)	($0.32)	$0.12	$0.08	($0.33)	($0.65)	$0.38
Weighted Average Basic Shares Outstanding	46.60M	46.05M	46.15M	45.95M	45.73M	45.21M	45.33M	45.13M	44.89M	44.40M	44.44M
Diluted Earnings per Share	($0.15)	$0.34	$0.19	$0.08	($0.34)	($0.32)	$0.12	$0.08	($0.33)	($0.62)	$0.37
Weighted Average Diluted Shares Outstanding	46.60M	46.26M	46.43M	46.04M	45.73M	45.21M	45.60M	45.47M	44.89M	45.89M	45.82M
Weighted Average Basic & Diluted Shares Outstanding	46.84M	46.76M	46.32M	45.99M	45.92M	45.92M	45.47M	45.21M	45.08M	44.99M	44.65M

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-102	148	-2.79	-134	363	60	35	-22	-28	-44	21
Net Cash From Operating Activities	188	181	78	232	186	145	104	25	50	38	65
Net Cash From Continuing Operating Activities	188	181	78	232	186	145	104	25	50	38	65
Net Income / (Loss) Continuing Operations	13	-20	5.65	78	32	61	38	31	9.76	31	31
Consolidated Net Income / (Loss)	13	-20	5.65	78	32	61	38	31	9.76	31	31
Depreciation Expense	82	87	87	73	61	54	51	52	58	26	20
Amortization Expense	11	13	16	34	17	13	2.29	1.59	1.59	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	36	76	84	47	37	32	24	18	14	12	7.47
Changes in Operating Assets and Liabilities, net	46	26	-115	0.26	39	-14	-12	-77	-34	-30	6.91
Net Cash From Investing Activities	-53	-55	-59	-412	-280	-62	-54	-35	-341	-46	-43
Net Cash From Continuing Investing Activities	-53	-55	-59	-412	-280	-62	-54	-35	-341	-46	-43
Purchase of Property, Plant & Equipment	-36	-41	-48	-29	-23	-16	-24	-15	-13	-7.54	-12
Acquisitions	0.00	0.00	2.07	-354	-225	0.00	0.00	-4.61	-314	-26	-21
Other Investing Activities, net	-16	-14	-13	-29	-32	-46	-31	-15	-14	-12	-10
Net Cash From Financing Activities	-236	23	-21	47	456	-23	-14	-9.88	264	-37	-0.21
Net Cash From Continuing Financing Activities	-235	23	-21	47	456	-23	-14	-9.88	264	-37	-0.21
Repayment of Debt	-391	-2.97	0.00	0.00	-201	-92	-77	-105	-35	0.00	0.00
Repurchase of Common Equity	0.00	0.00	-52	0.00	-53	0.00	0.00	-	-	-50	-24
Issuance of Debt	166	0.00	0.00	-	710	0.00	0.00	59	287	0.00	0.00
Issuance of Common Equity	39	23	40	67	106	79	70	44	18	17	22
Other Financing Activities, net	-49	3.17	-8.93	-20	-105	-9.67	-6.78	-8.29	-6.49	-3.63	2.09
Effect of Exchange Rate Changes	-1.72	-1.35	-0.94	-0.97	0.44	0.15	-1.23	-2.03	-0.06	-0.00	-0.28
Cash Interest Paid	1.62	1.44	1.44	1.92	0.52	3.58	7.49	6.55	5.34	0.08	0.06
Cash Income Taxes Paid	11	20	19	-1.73	10	7.76	3.49	7.78	11	12	9.16

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	16	-194	15	28	49	38	45	62	3.17	69	15
Net Cash From Operating Activities	26	56	23	59	50	38	57	73	13	82	21
Net Cash From Continuing Operating Activities	26	56	23	59	50	38	57	73	13	82	21
Net Income / (Loss) Continuing Operations	-7.02	16	8.63	3.74	-16	-14	5.55	3.45	-15	-28	17
Consolidated Net Income / (Loss)	-7.02	16	8.63	3.74	-16	-14	5.55	3.45	-15	-28	17
Depreciation Expense	20	20	20	21	21	22	22	22	22	22	22
Amortization Expense	2.58	3.12	2.35	2.94	2.90	3.26	3.06	3.02	3.29	3.57	3.95
Non-Cash Adjustments To Reconcile Net Income	7.80	-2.84	12	16	11	17	17	16	25	19	21
Changes in Operating Assets and Liabilities, net	2.58	20	-20	15	31	10	9.93	28	-23	66	-42
Net Cash From Investing Activities	-16	-14	-13	-14	-12	-12	-14	-15	-14	-17	-16
Net Cash From Continuing Investing Activities	-16	-14	-13	-14	-12	-12	-14	-15	-14	-17	-16
Purchase of Property, Plant & Equipment	-11	-9.09	-8.87	-9.55	-8.96	-9.07	-11	-12	-10	-14	-13
Other Investing Activities, net	-4.57	-4.48	-4.47	-4.00	-3.38	-3.30	-3.56	-3.19	-3.50	-3.56	-8.59
Net Cash From Financing Activities	4.04	-234	3.55	-17	12	13	2.83	3.60	3.86	3.56	9.06
Net Cash From Continuing Financing Activities	4.04	-234	3.55	-17	12	13	2.83	3.60	3.86	3.56	9.06
Issuance of Common Equity	8.27	25	5.00	0.10	8.04	0.18	7.83	3.09	12	0.64	18
Other Financing Activities, net	-4.23	-34	-1.45	-17	3.88	16	-5.01	0.51	-8.25	2.92	-9.36
Effect of Exchange Rate Changes	1.57	-2.60	1.68	-0.25	-0.56	-0.89	-0.61	-0.03	0.18	0.48	0.70

This table presents Omnicell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	2,121	2,227	2,211	2,142	1,825	1,241	1,081	1,016	935	579	560
Total Current Assets	815	928	882	781	829	483	397	352	315	264	283
Cash & Equivalents	369	468	330	349	486	127	67	32	54	82	126
Accounts Receivable	256	252	299	241	190	218	196	190	150	108	83
Inventories, net	89	110	148	120	96	108	101	96	69	47	32
Prepaid Expenses	26	26	27	22	16	14	21	20	29	20	24
Other Current Assets	75	72	77	48	41	15	12	13	13	7.77	7.22
Plant, Property, & Equipment, net	113	109	94	71	59	54	52	43	42	32	36
Total Noncurrent Assets	1,193	1,191	1,235	1,291	936	703	633	621	578	282	241
Noncurrent Note & Lease Receivables	53	43	33	18	22	20	17	15	21	14	11
Goodwill	735	736	734	739	499	337	336	338	328	148	123
Intangible Assets	188	211	243	278	168	125	144	168	190	90	83
Noncurrent Deferred & Refundable Income Taxes	57	33	22	16	15	14	15	9.45	4.04	2.36	1.14
Other Noncurrent Operating Assets	160	168	203	240	231	208	121	91	35	28	23
Total Liabilities & Shareholders' Equity	2,121	2,227	2,211	2,142	1,825	1,241	1,081	1,016	935	579	560
Total Liabilities	878	1,038	1,081	996	857	396	402	462	503	176	170
Total Current Liabilities	596	368	428	876	276	237	205	205	181	125	112
Short-Term Debt	174	0.00	-	488	0.00	-	-	15	8.41	0.00	-
Accounts Payable	52	45	63	72	40	46	38	48	27	23	19
Accrued Expenses	168	149	173	133	80	56	43	36	31	30	19
Current Deferred Revenue	141	122	119	112	100	91	82	79	88	54	54
Current Employee Benefit Liabilities	60	52	73	71	56	44	42	27	27	18	20
Total Noncurrent Liabilities	282	670	652	120	581	159	197	257	323	52	58
Long-Term Debt	166	570	567	0.00	467	50	135	195	246	0.00	-
Noncurrent Deferred Revenue	76	59	37	20	5.67	7.08	11	11	17	18	20
Noncurrent Deferred & Payable Income Tax Liabilities	1.11	1.62	2.10	52	40	39	41	41	52	22	30
Other Noncurrent Operating Liabilities	38	40	46	48	68	62	9.56	9.83	8.21	12	7.02
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,243	1,189	1,130	1,147	968	845	680	554	432	402	390
Total Preferred & Common Equity	1,243	1,189	1,130	1,147	968	845	680	554	432	402	390
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,243	1,189	1,130	1,147	968	845	680	554	432	402	390
Common Stock	1,168	1,122	1,047	1,025	920	781	678	586	526	490	457
Retained Earnings	383	370	391	369	291	259	197	160	100	100	69
Treasury Stock	-290	-	-290	-238	-238	-185	-185	-185	-185	-185	-135
Accumulated Other Comprehensive Income / (Loss)	-17	-13	-17	-8.41	-5.52	-9.45	-11	-6.11	-9.52	-2.73	-1.36

This table presents Omnicell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,151	2,304	2,292	2,284	2,222	2,194	2,251	2,180
Total Current Assets	840	1,011	996	990	914	881	935	849
Cash & Equivalents	387	571	557	512	447	399	340	266
Accounts Receivable	252	252	241	249	273	274	322	354
Inventories, net	91	95	93	103	116	131	141	147
Prepaid Expenses	27	29	22	27	28	24	28	25
Other Current Assets	83	65	82	99	50	54	103	57
Plant, Property, & Equipment, net	116	112	111	109	107	103	98	88
Total Noncurrent Assets	1,196	1,181	1,185	1,185	1,201	1,209	1,217	1,242
Noncurrent Note & Lease Receivables	53	51	50	44	42	35	33	34
Goodwill	736	737	735	735	734	736	735	731
Intangible Assets	183	194	199	205	219	227	235	251
Noncurrent Deferred & Refundable Income Taxes	61	42	41	37	36	33	30	17
Other Noncurrent Operating Assets	164	157	159	163	170	179	186	209
Total Liabilities & Shareholders' Equity	2,151	2,304	2,292	2,284	2,222	2,194	2,251	2,180
Total Liabilities	894	1,072	1,089	1,095	1,034	1,030	1,108	1,044
Total Current Liabilities	608	962	407	416	369	370	454	377
Short-Term Debt	175	572	-	-	-	-	-	0.00
Accounts Payable	53	48	50	43	50	47	63	74
Accrued Expenses	174	144	158	167	150	146	199	146
Current Deferred Revenue	160	152	150	165	125	125	143	114
Current Employee Benefit Liabilities	46	45	49	41	44	52	48	43
Total Noncurrent Liabilities	287	111	682	679	665	660	654	668
Long-Term Debt	167	0.00	571	570	569	568	567	566
Noncurrent Deferred Revenue	78	70	68	65	55	49	42	35
Noncurrent Deferred & Payable Income Tax Liabilities	1.17	1.41	1.33	1.49	1.57	1.51	1.56	16
Other Noncurrent Operating Liabilities	41	40	41	42	39	42	43	51
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,257	1,231	1,203	1,189	1,187	1,164	1,143	1,135
Total Preferred & Common Equity	1,257	1,231	1,203	1,189	1,187	1,164	1,143	1,135
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,257	1,231	1,203	1,189	1,187	1,164	1,143	1,135
Common Stock	1,185	1,165	1,150	1,139	1,110	1,089	1,073	1,031
Retained Earnings	376	367	358	355	385	379	376	419
Accumulated Other Comprehensive Income / (Loss)	-14	-10	-15	-15	-17	-14	-16	-24
Other Equity Adjustments	-290	-	-290	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.04%	-11.48%	14.48%	26.88%	-0.54%	13.94%	10.47%	2.42%	43.62%	9.90%	15.85%
EBITDA Growth	49.21%	-20.85%	-41.68%	61.21%	-23.49%	57.14%	54.93%	-21.00%	1.45%	4.52%	28.81%
EBIT Growth	227.28%	-719.73%	-103.72%	124.90%	-60.30%	107.58%	689.36%	-65.23%	-71.94%	-4.66%	38.47%
NOPAT Growth	100.68%	-1,400.99%	-101.54%	170.89%	-40.05%	38.23%	-37.62%	368.40%	-50.25%	3.69%	29.11%
Net Income Growth	161.51%	-460.68%	-92.74%	141.81%	-47.51%	62.58%	23.63%	212.81%	-68.28%	0.79%	27.27%
EPS Growth	160.00%	-475.00%	-92.59%	118.92%	-48.25%	53.76%	17.72%	203.85%	-69.05%	1.20%	23.88%
Operating Cash Flow Growth	3.66%	132.83%	-66.45%	24.72%	28.18%	39.48%	318.64%	-50.23%	29.66%	-40.94%	17.91%
Free Cash Flow Firm Growth	48.12%	162.42%	64.49%	-63.27%	-416.42%	43.48%	222.94%	91.39%	-1,149.32%	-306.17%	-54.07%
Invested Capital Growth	-5.87%	-5.54%	6.27%	35.52%	23.53%	2.70%	2.16%	15.97%	97.16%	21.18%	8.08%
Revenue Q/Q Growth	4.51%	-3.27%	-1.02%	5.78%	0.10%	4.25%	1.99%	3.05%	6.90%	1.84%	3.71%
EBITDA Q/Q Growth	50.96%	25.69%	-30.98%	-2.15%	0.09%	6.12%	3.63%	-0.03%	15.06%	-0.78%	5.22%
EBIT Q/Q Growth	254.88%	45.81%	-106.15%	-9.68%	-21.62%	7.81%	6.13%	48.47%	16.84%	-4.50%	5.38%
NOPAT Q/Q Growth	100.67%	30.07%	-102.83%	-2.03%	2.65%	9.85%	-30.06%	174.89%	18.41%	-3.39%	8.32%
Net Income Q/Q Growth	170.85%	40.79%	-88.24%	-2.99%	-15.08%	13.51%	-30.34%	254.74%	20.43%	-4.89%	8.58%
EPS Q/Q Growth	169.23%	40.00%	-88.24%	-5.81%	-15.91%	11.72%	-32.61%	259.09%	18.18%	-4.55%	7.79%
Operating Cash Flow Q/Q Growth	10.54%	-19.45%	40.75%	-6.76%	28.86%	-8.01%	71.28%	-44.22%	-14.82%	4.64%	33.42%
Free Cash Flow Firm Q/Q Growth	46.14%	-43.27%	68.96%	8.70%	-516.81%	-37.51%	188.44%	3.86%	-15.17%	7.71%	365.26%
Invested Capital Q/Q Growth	-1.45%	-1.44%	-4.77%	15.57%	26.28%	2.76%	-1.59%	11.36%	4.60%	-4.08%	-3.82%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.35%	43.31%	45.45%	49.00%	46.32%	48.71%	47.29%	44.71%	45.56%	51.17%	53.04%
EBITDA Margin	10.71%	6.96%	7.78%	15.28%	12.03%	15.64%	11.34%	8.08%	10.48%	14.83%	15.60%
Operating Margin	0.03%	-3.04%	-0.18%	7.91%	3.98%	8.73%	5.64%	1.56%	3.08%	10.04%	11.25%
EBIT Margin	2.30%	-1.75%	-0.19%	5.83%	3.29%	8.24%	4.52%	0.63%	1.86%	9.54%	11.00%
Profit (Net Income) Margin	1.13%	-1.78%	0.44%	6.88%	3.61%	6.84%	4.79%	4.28%	1.40%	6.35%	6.92%
Tax Burden Percent	48.96%	101.31%	-230.25%	117.94%	109.69%	82.96%	105.93%	676.37%	75.19%	66.52%	62.92%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	51.04%	0.00%	0.00%	-17.94%	-9.69%	17.04%	-5.93%	-576.37%	24.82%	33.48%	37.08%
Return on Invested Capital (ROIC)	0.01%	-1.84%	-0.12%	9.45%	4.54%	8.58%	6.36%	11.06%	3.38%	11.07%	12.27%
ROIC Less NNEP Spread (ROIC-NNEP)	33.80%	0.55%	3.75%	-36.60%	18.67%	90.18%	-1.21%	-12.72%	-7.41%	12.60%	12.86%
Return on Net Nonoperating Assets (RNNOA)	1.02%	0.08%	0.62%	-2.08%	-0.99%	-0.53%	-0.24%	-4.87%	-1.04%	-3.31%	-4.01%
Return on Equity (ROE)	1.03%	-1.76%	0.50%	7.36%	3.55%	8.05%	6.12%	6.19%	2.34%	7.76%	8.26%
Cash Return on Invested Capital (CROIC)	6.06%	3.86%	-6.20%	-20.72%	-16.51%	5.91%	4.22%	-3.73%	-62.01%	-8.08%	4.50%
Operating Return on Assets (OROA)	1.18%	-0.91%	-0.11%	3.33%	1.91%	6.37%	3.40%	0.46%	1.71%	8.12%	9.22%
Return on Assets (ROA)	0.58%	-0.92%	0.26%	3.92%	2.10%	5.28%	3.60%	3.13%	1.29%	5.40%	5.80%
Return on Common Equity (ROCE)	1.03%	-1.76%	0.50%	7.36%	3.55%	8.05%	6.12%	6.19%	2.34%	7.76%	8.26%
Return on Equity Simple (ROE_SIMPLE)	1.01%	-1.71%	0.50%	6.79%	3.33%	7.26%	5.55%	5.51%	2.26%	7.64%	7.82%
Net Operating Profit after Tax (NOPAT)	0.17	-24	-1.63	106	39	65	47	75	16	32	31
NOPAT Margin	0.01%	-2.13%	-0.13%	9.33%	4.37%	7.25%	5.97%	10.58%	2.31%	6.68%	7.08%
Net Nonoperating Expense Percent (NNEP)	-33.78%	-2.39%	-3.88%	46.05%	-14.13%	-81.61%	7.56%	23.78%	10.79%	-1.53%	-0.59%
Return On Investment Capital (ROIC_SIMPLE)	0.01%	-1.39%	-0.10%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	57.65%	56.69%	54.55%	51.00%	53.68%	51.29%	52.71%	55.29%	54.44%	48.83%	46.96%
SG&A Expenses to Revenue	34.19%	37.89%	37.53%	34.40%	34.48%	32.32%	33.42%	33.88%	34.18%	34.58%	35.49%
R&D to Revenue	8.13%	8.47%	8.10%	6.69%	7.86%	7.65%	8.24%	9.26%	8.31%	7.26%	6.31%
Operating Expenses to Revenue	42.32%	46.35%	45.63%	41.09%	42.34%	39.97%	41.65%	43.14%	42.49%	41.13%	41.80%
Earnings before Interest and Taxes (EBIT)	26	-20	-2.45	66	29	74	36	4.51	13	46	49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	119	80	101	173	107	140	89	58	73	72	69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.66	1.44	1.99	6.91	5.25	4.05	3.57	3.32	2.87	2.74	3.02
Price to Tangible Book Value (P/TBV)	6.44	7.07	14.72	60.91	16.93	8.93	12.13	37.95	0.00	6.68	6.38
Price to Revenue (P/Rev)	1.85	1.49	1.74	7.00	5.69	3.82	3.08	2.58	1.78	2.27	2.67
Price to Earnings (P/E)	164.55	0.00	398.59	101.85	157.72	55.87	64.32	60.28	126.89	35.80	38.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.61%	0.00%	0.25%	0.98%	0.63%	1.79%	1.55%	1.66%	0.79%	2.79%	2.59%
Enterprise Value to Invested Capital (EV/IC)	1.67	1.40	1.82	6.27	5.33	4.36	3.34	2.76	2.28	3.18	3.99
Enterprise Value to Revenue (EV/Rev)	1.83	1.58	1.92	7.13	5.67	3.73	3.17	2.83	2.07	2.10	2.39
Enterprise Value to EBITDA (EV/EBITDA)	17.07	22.70	24.66	46.64	47.14	23.88	27.95	35.02	19.71	14.17	15.32
Enterprise Value to EBIT (EV/EBIT)	79.46	0.00	0.00	122.23	172.37	45.31	70.05	447.12	110.79	22.03	21.72
Enterprise Value to NOPAT (EV/NOPAT)	12,324.22	0.00	0.00	76.43	129.82	51.53	53.05	26.76	89.33	31.50	33.76
Enterprise Value to Operating Cash Flow (EV/OCF)	10.83	10.01	31.98	34.81	27.22	23.10	24.00	81.24	28.81	26.47	16.16
Enterprise Value to Free Cash Flow (EV/FCFF)	26.77	35.34	0.00	0.00	0.00	74.77	79.90	0.00	0.00	0.00	91.97
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.27	0.48	0.50	0.43	0.48	0.06	0.20	0.38	0.59	0.00	0.00
Long-Term Debt to Equity	0.13	0.48	0.50	0.00	0.48	0.06	0.20	0.35	0.57	0.00	0.00
Financial Leverage	0.03	0.15	0.16	0.06	-0.05	-0.01	0.20	0.38	0.14	-0.26	-0.31
Leverage Ratio	1.79	1.91	1.91	1.88	1.69	1.52	1.70	1.98	1.82	1.44	1.42
Compound Leverage Factor	1.79	1.91	1.91	1.88	1.69	1.52	1.70	1.98	1.82	1.44	1.42
Debt to Total Capital	21.51%	32.39%	33.39%	29.86%	32.56%	5.59%	16.61%	27.49%	37.06%	0.00%	0.00%
Short-Term Debt to Total Capital	11.01%	0.00%	0.00%	29.86%	0.00%	0.00%	0.00%	1.99%	1.23%	0.00%	0.00%
Long-Term Debt to Total Capital	10.50%	32.39%	33.39%	0.00%	32.56%	5.59%	16.61%	25.50%	35.83%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.49%	67.61%	66.61%	70.14%	67.44%	94.42%	83.39%	72.51%	62.94%	100.00%	100.00%
Debt to EBITDA	2.86	7.13	5.62	2.82	4.35	0.36	1.52	3.65	3.48	0.00	0.00
Net Debt to EBITDA	-0.24	1.27	2.34	0.80	-0.17	-0.55	0.76	3.08	2.74	0.00	0.00
Long-Term Debt to EBITDA	1.40	7.13	5.62	0.00	4.35	0.36	1.52	3.38	3.37	0.00	0.00
Debt to NOPAT	2,064.93	-23.34	-348.42	4.62	11.99	0.77	2.88	2.79	15.79	0.00	0.00
Net Debt to NOPAT	-172.60	-4.17	-145.26	1.32	-0.48	-1.19	1.45	2.36	12.41	0.00	0.00
Long-Term Debt to NOPAT	1,008.44	-23.34	-348.42	0.00	11.99	0.77	2.88	2.59	15.27	0.00	0.00
Altman Z-Score	2.35	2.01	2.33	5.59	4.68	6.65	4.93	3.50	2.59	5.38	5.77
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.37	2.52	2.06	0.89	3.00	2.04	1.94	1.72	1.74	2.12	2.52
Quick Ratio	1.05	1.96	1.47	0.67	2.45	1.46	1.29	1.08	1.13	1.53	1.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	76	51	-82	-231	-142	45	31	-25	-295	-24	11
Operating Cash Flow to CapEx	514.83%	436.64%	163.63%	800.25%	813.72%	912.34%	438.73%	161.88%	371.14%	510.29%	546.58%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.52	0.60	0.57	0.58	0.77	0.75	0.73	0.92	0.85	0.84
Accounts Receivable Turnover	4.38	4.16	4.80	5.25	4.37	4.33	4.08	4.19	5.39	5.08	6.24
Inventory Turnover	6.45	5.05	5.29	5.34	4.69	4.41	4.21	4.76	6.54	6.06	6.57
Fixed Asset Turnover	10.05	11.33	15.70	17.39	15.75	16.97	16.73	16.85	18.73	14.15	12.34
Accounts Payable Turnover	13.25	12.00	10.48	10.33	11.05	10.90	9.61	10.46	15.24	11.25	11.53
Days Sales Outstanding (DSO)	83.42	87.74	76.10	69.49	83.55	84.35	89.54	87.15	67.73	71.83	58.51
Days Inventory Outstanding (DIO)	56.57	72.31	69.05	68.35	77.86	82.85	86.64	76.61	55.83	60.27	55.54
Days Payable Outstanding (DPO)	27.55	30.43	34.82	35.35	33.03	33.48	37.97	34.90	23.95	32.45	31.65
Cash Conversion Cycle (CCC)	112.44	129.62	110.32	102.49	128.38	133.72	138.22	128.87	99.61	99.65	82.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,215	1,291	1,366	1,286	949	768	748	732	631	320	264
Invested Capital Turnover	0.89	0.86	0.98	1.01	1.04	1.18	1.06	1.05	1.46	1.66	1.73
Increase / (Decrease) in Invested Capital	-76	-76	81	337	181	20	16	101	311	56	20
Enterprise Value (EV)	2,034	1,813	2,487	8,068	5,059	3,350	2,495	2,017	1,438	1,019	1,053
Market Capitalization	2,062	1,711	2,251	7,929	5,078	3,427	2,427	1,840	1,238	1,101	1,179
Book Value per Share	$26.84	$26.15	$25.31	$26.10	$22.87	$20.15	$17.15	$14.61	$11.82	$11.36	$10.96
Tangible Book Value per Share	$6.92	$5.32	$3.43	$2.96	$7.09	$9.15	$5.05	$1.28	($2.37)	$4.65	$5.19
Total Capital	1,584	1,759	1,697	1,635	1,435	895	815	764	686	402	390
Total Debt	341	570	567	488	467	50	135	210	254	0.00	0.00
Total Long-Term Debt	166	570	567	0.00	467	50	135	195	246	0.00	0.00
Net Debt	-28	102	236	139	-19	-77	68	178	200	-82	-126
Capital Expenditures (CapEx)	36	41	48	29	23	16	24	15	13	7.54	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	25	92	123	44	67	119	125	130	88	57	45
Debt-free Net Working Capital (DFNWC)	394	560	453	393	553	246	193	162	143	139	171
Net Working Capital (NWC)	220	560	453	-95	553	246	193	147	134	139	171
Net Nonoperating Expense (NNE)	-12	-4.04	-7.27	28	6.78	3.67	9.30	45	6.34	1.59	0.68
Net Nonoperating Obligations (NNO)	-28	102	236	139	-19	-77	68	178	200	-82	-126
Total Depreciation and Amortization (D&A)	94	100	103	107	78	66	54	53	60	26	20
Debt-free, Cash-free Net Working Capital to Revenue	2.24%	8.00%	9.49%	3.86%	7.52%	13.27%	15.92%	18.22%	12.71%	11.82%	10.24%
Debt-free Net Working Capital to Revenue	35.44%	48.80%	34.98%	34.69%	61.98%	27.45%	24.46%	22.77%	20.54%	28.79%	38.80%
Net Working Capital to Revenue	19.76%	48.80%	34.98%	-8.43%	61.98%	27.45%	24.46%	20.63%	19.33%	28.79%	38.80%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.27	($0.45)	$0.13	$1.79	$0.76	$1.48	$0.96	$0.55	$0.02	$0.86	$0.86
Adjusted Weighted Average Basic Shares Outstanding	46.05M	45.21M	44.40M	43.48M	42.58M	41.46M	39.24M	37.48M	36.16M	35.86M	35.65M
Adjusted Diluted Earnings per Share	$0.27	($0.45)	$0.12	$1.62	$0.74	$1.43	$0.93	$0.53	$0.02	$0.84	$0.83
Adjusted Weighted Average Diluted Shares Outstanding	46.26M	45.21M	45.89M	47.94M	43.74M	42.94M	40.56M	38.71M	36.86M	36.72M	36.62M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.76M	45.92M	44.99M	44.42M	43.04M	42.47M	40.80M	38.78M	36.95M	35.83M	36.17M
Normalized Net Operating Profit after Tax (NOPAT)	0.24	-24	-1.63	63	25	65	31	7.80	16	30	31
Normalized NOPAT Margin	0.02%	-2.13%	-0.13%	5.53%	2.79%	7.25%	3.95%	1.09%	2.31%	6.20%	7.08%
Pre Tax Income Margin	2.30%	-1.75%	-0.19%	5.83%	3.29%	8.24%	4.52%	0.63%	1.86%	9.54%	11.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	924.40%	0.00%	164.74%	0.00%	0.00%	0.00%	0.00%	162.62%	78.94%

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.55%	18.56%	-5.44%	-7.42%	-15.30%	-13.04%	-14.19%	-9.78%	-8.84%	-4.30%	17.43%
EBITDA Growth	106.33%	622.06%	6.79%	-14.30%	54.79%	165.61%	-25.78%	0.30%	-86.58%	-127.81%	-13.84%
EBIT Growth	46.55%	227.45%	57.50%	-32.86%	15.82%	47.86%	-57.37%	13.32%	-526.20%	-621.96%	-25.76%
NOPAT Growth	46.82%	150.88%	74.48%	-32.92%	4.86%	39.09%	-84.39%	-79.16%	-291.33%	-212.75%	-51.58%
Net Income Growth	55.20%	210.21%	55.41%	8.23%	-4.51%	49.40%	-66.90%	-61.95%	-282.64%	-303.19%	-42.78%
EPS Growth	55.88%	206.25%	58.33%	0.00%	-3.03%	48.39%	-67.57%	-60.00%	-294.12%	-321.43%	-39.34%
Operating Cash Flow Growth	-48.10%	46.60%	-60.09%	-19.48%	291.17%	-53.24%	169.22%	863.30%	179.83%	37.77%	-50.74%
Free Cash Flow Firm Growth	-74.88%	41.76%	-36.26%	40.81%	1,031.42%	155.25%	142.10%	117.00%	97.32%	65.71%	6.17%
Invested Capital Growth	-2.82%	-5.87%	-5.86%	-8.63%	-8.97%	-5.54%	-8.73%	-5.70%	-0.33%	6.27%	28.96%
Revenue Q/Q Growth	-12.13%	8.66%	2.03%	12.45%	-4.90%	-13.33%	-0.10%	2.87%	-2.37%	-14.48%	5.03%
EBITDA Q/Q Growth	-72.05%	36.67%	6.82%	405.71%	-2.20%	-79.79%	-14.28%	813.39%	141.46%	-122.87%	15.84%
EBIT Q/Q Growth	-140.38%	102.98%	41.84%	145.97%	3.70%	-350.84%	-39.54%	157.64%	40.36%	-305.08%	60.73%
NOPAT Q/Q Growth	-197.74%	70.79%	231.65%	109.61%	6.50%	-685.74%	27.50%	113.62%	40.13%	-250.12%	70.19%
Net Income Q/Q Growth	-144.33%	83.57%	131.06%	123.83%	-9.05%	-358.87%	60.91%	123.01%	47.20%	-269.36%	84.96%
EPS Q/Q Growth	-144.12%	78.95%	137.50%	123.53%	-6.25%	-366.67%	50.00%	124.24%	46.77%	-267.57%	85.00%
Operating Cash Flow Q/Q Growth	-53.97%	147.49%	-61.24%	17.51%	30.04%	-32.62%	-21.80%	470.89%	-84.46%	287.97%	321.70%
Free Cash Flow Firm Q/Q Growth	-67.90%	3.03%	-29.87%	8.31%	81.15%	-53.67%	54.91%	816.46%	89.25%	64.70%	37.43%
Invested Capital Q/Q Growth	-0.27%	-1.45%	1.27%	-2.36%	-3.41%	-1.44%	-1.71%	-2.72%	0.23%	-4.77%	1.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	41.14%	46.19%	43.29%	41.31%	37.63%	40.72%	44.18%	44.97%	43.02%	40.90%	45.71%
EBITDA Margin	4.84%	15.21%	12.09%	11.55%	2.57%	2.50%	10.71%	12.48%	1.41%	-3.31%	12.38%
Operating Margin	-4.31%	4.04%	2.32%	1.16%	-8.88%	-9.03%	1.24%	2.59%	-7.90%	-12.89%	5.31%
EBIT Margin	-3.53%	7.69%	4.12%	2.96%	-7.24%	-7.15%	2.47%	4.08%	-7.29%	-11.93%	4.98%
Profit (Net Income) Margin	-2.60%	5.16%	3.06%	1.35%	-6.37%	-5.55%	1.86%	1.15%	-5.16%	-9.54%	4.82%
Tax Burden Percent	73.69%	67.13%	74.22%	45.57%	87.91%	77.63%	75.22%	28.27%	70.81%	79.99%	96.86%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	32.87%	25.78%	54.43%	0.00%	0.00%	24.78%	71.73%	0.00%	0.00%	3.14%
Return on Invested Capital (ROIC)	-2.79%	2.41%	1.44%	0.45%	-5.24%	-5.46%	0.81%	0.66%	-5.11%	-8.82%	5.28%
ROIC Less NNEP Spread (ROIC-NNEP)	14.96%	22.95%	7.53%	2.93%	-5.51%	-4.28%	2.12%	1.18%	-4.70%	-9.65%	4.54%
Return on Net Nonoperating Assets (RNNOA)	0.08%	0.69%	0.38%	0.23%	-0.67%	-0.62%	0.38%	0.25%	-1.12%	-1.59%	0.61%
Return on Equity (ROE)	-2.71%	3.10%	1.83%	0.68%	-5.91%	-6.08%	1.19%	0.91%	-6.23%	-10.40%	5.89%
Cash Return on Invested Capital (CROIC)	3.40%	6.06%	4.09%	6.92%	7.58%	3.86%	6.59%	4.08%	-1.22%	-6.20%	-20.79%
Operating Return on Assets (OROA)	-1.81%	3.93%	1.94%	1.43%	-3.52%	-3.70%	1.33%	2.33%	-4.23%	-7.10%	3.08%
Return on Assets (ROA)	-1.33%	2.64%	1.44%	0.65%	-3.10%	-2.87%	1.00%	0.66%	-2.99%	-5.68%	2.98%
Return on Common Equity (ROCE)	-2.71%	3.10%	1.83%	0.68%	-5.91%	-6.08%	1.19%	0.91%	-6.23%	-10.40%	5.89%
Return on Equity Simple (ROE_SIMPLE)	1.69%	0.00%	-1.44%	-1.73%	-1.77%	0.00%	-2.90%	-1.99%	-1.54%	0.00%	4.23%
Net Operating Profit after Tax (NOPAT)	-8.13	8.32	4.87	1.47	-15	-16	2.79	2.19	-16	-27	18
NOPAT Margin	-3.02%	2.71%	1.73%	0.53%	-6.21%	-6.32%	0.93%	0.73%	-5.53%	-9.02%	5.14%
Net Nonoperating Expense Percent (NNEP)	-17.75%	-20.55%	-6.09%	-2.48%	0.27%	-1.17%	-1.31%	-0.52%	-0.41%	0.83%	0.74%
Return On Investment Capital (ROIC_SIMPLE)	-0.51%	0.53%	-	-	-	-0.93%	-	-	-	-1.58%	-
Cost of Revenue to Revenue	58.86%	53.81%	56.71%	58.69%	62.37%	59.28%	55.82%	55.03%	56.98%	59.10%	54.29%
SG&A Expenses to Revenue	37.84%	33.67%	33.46%	32.52%	37.54%	39.39%	34.81%	34.64%	43.05%	44.24%	33.17%
R&D to Revenue	7.61%	8.49%	7.51%	7.62%	8.96%	10.36%	8.13%	7.74%	7.87%	9.55%	7.23%
Operating Expenses to Revenue	45.45%	42.16%	40.97%	40.15%	46.50%	49.75%	42.94%	42.38%	50.92%	53.79%	40.40%
Earnings before Interest and Taxes (EBIT)	-9.53	24	12	8.20	-18	-19	7.38	12	-21	-36	17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	13	47	34	32	6.32	6.47	32	37	4.09	-9.85	43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.30	1.66	1.63	1.03	1.13	1.44	1.71	2.85	2.31	1.99	3.39
Price to Tangible Book Value (P/TBV)	4.83	6.44	6.68	4.64	5.41	7.07	8.69	16.50	15.26	14.72	25.18
Price to Revenue (P/Rev)	1.44	1.85	1.88	1.15	1.22	1.49	1.72	2.69	2.08	1.74	2.94
Price to Earnings (P/E)	77.17	164.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	398.59	80.24
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.30%	0.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.25%	1.25%
Enterprise Value to Invested Capital (EV/IC)	1.31	1.67	1.63	1.03	1.12	1.40	1.65	2.62	2.09	1.82	2.90
Enterprise Value to Revenue (EV/Rev)	1.40	1.83	1.89	1.16	1.27	1.58	1.82	2.82	2.26	1.92	3.17
Enterprise Value to EBITDA (EV/EBITDA)	12.63	17.07	25.43	16.39	17.06	22.70	33.98	46.76	38.46	24.66	28.42
Enterprise Value to EBIT (EV/EBIT)	46.89	79.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	104.20
Enterprise Value to NOPAT (EV/NOPAT)	240.66	12,324.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	72.39
Enterprise Value to Operating Cash Flow (EV/OCF)	9.71	10.83	11.82	6.16	6.41	10.01	9.60	18.46	26.90	31.98	75.17
Enterprise Value to Free Cash Flow (EV/FCFF)	38.07	26.77	38.60	14.26	14.12	35.34	23.87	62.40	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.27	0.27	0.46	0.47	0.48	0.48	0.48	0.49	0.50	0.50	0.50
Long-Term Debt to Equity	0.13	0.13	0.00	0.47	0.48	0.48	0.48	0.49	0.50	0.50	0.50
Financial Leverage	0.01	0.03	0.05	0.08	0.12	0.15	0.18	0.22	0.24	0.16	0.13
Leverage Ratio	1.81	1.79	1.87	1.90	1.95	1.91	1.89	1.92	1.97	1.91	1.88
Compound Leverage Factor	1.81	1.79	1.87	1.90	1.95	1.91	1.89	1.92	1.97	1.91	1.88
Debt to Total Capital	21.35%	21.51%	31.72%	32.20%	32.43%	32.39%	32.39%	32.81%	33.18%	33.39%	33.26%
Short-Term Debt to Total Capital	10.92%	11.01%	31.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	10.43%	10.50%	0.00%	32.20%	32.43%	32.39%	32.39%	32.81%	33.18%	33.39%	33.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.65%	78.49%	68.28%	67.80%	67.57%	67.61%	67.61%	67.19%	66.82%	66.61%	66.74%
Debt to EBITDA	2.71	2.86	7.25	7.44	6.95	7.13	8.95	7.61	7.61	5.62	3.87
Net Debt to EBITDA	-0.36	-0.24	0.02	0.19	0.71	1.27	1.92	2.26	3.05	2.34	2.05
Long-Term Debt to EBITDA	1.32	1.40	0.00	7.44	6.95	7.13	8.95	7.61	7.61	5.62	3.87
Debt to NOPAT	51.68	2,064.93	-23.07	-21.32	-24.14	-23.34	-16.30	-23.12	-26.69	-348.42	9.86
Net Debt to NOPAT	-6.90	-172.60	-0.06	-0.54	-2.46	-4.17	-3.50	-6.86	-10.67	-145.26	5.22
Long-Term Debt to NOPAT	25.25	1,008.44	0.00	-21.32	-24.14	-23.34	-16.30	-23.12	-26.69	-348.42	9.86
Altman Z-Score	1.98	2.35	1.85	1.70	1.71	2.01	2.26	3.04	2.45	2.28	3.37
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.38	1.37	1.05	2.45	2.38	2.52	2.47	2.38	2.06	2.06	2.25
Quick Ratio	1.05	1.05	0.86	1.96	1.83	1.96	1.95	1.82	1.46	1.47	1.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	27	84	82	116	108	59	128	83	-12	-107	-304
Operating Cash Flow to CapEx	232.04%	619.73%	256.59%	614.60%	557.70%	423.53%	536.18%	626.80%	125.92%	600.75%	165.92%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.51	0.47	0.48	0.49	0.52	0.54	0.57	0.58	0.60	0.62
Accounts Receivable Turnover	4.54	4.38	4.06	4.20	3.86	4.16	3.78	4.23	4.14	4.80	4.45
Inventory Turnover	6.64	6.45	5.96	5.68	5.22	5.05	5.11	4.95	5.06	5.29	5.51
Fixed Asset Turnover	10.10	10.05	9.74	10.09	10.63	11.33	12.15	13.35	14.45	15.70	17.08
Accounts Payable Turnover	13.41	13.25	12.88	13.12	11.98	12.00	10.90	12.03	10.42	10.48	9.35
Days Sales Outstanding (DSO)	80.36	83.42	89.92	86.99	94.44	87.74	96.44	86.34	88.18	76.10	81.94
Days Inventory Outstanding (DIO)	54.94	56.57	61.22	64.22	69.95	72.31	71.41	73.80	72.14	69.05	66.21
Days Payable Outstanding (DPO)	27.22	27.55	28.33	27.81	30.47	30.43	33.49	30.35	35.02	34.82	39.03
Cash Conversion Cycle (CCC)	108.08	112.44	122.81	123.40	133.92	129.62	134.36	129.78	125.30	110.32	109.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,212	1,215	1,233	1,217	1,247	1,291	1,309	1,332	1,369	1,366	1,435
Invested Capital Turnover	0.92	0.89	0.84	0.85	0.84	0.86	0.86	0.90	0.92	0.98	1.03
Increase / (Decrease) in Invested Capital	-35	-76	-77	-115	-123	-76	-125	-81	-4.53	81	322
Enterprise Value (EV)	1,589	2,034	2,007	1,258	1,400	1,813	2,158	3,490	2,866	2,487	4,154
Market Capitalization	1,635	2,062	2,005	1,243	1,342	1,711	2,036	3,321	2,639	2,251	3,854
Book Value per Share	$26.88	$26.84	$26.77	$26.19	$25.89	$26.15	$26.26	$25.81	$25.40	$25.31	$25.64
Tangible Book Value per Share	$7.24	$6.92	$6.53	$5.84	$5.40	$5.32	$5.18	$4.47	$3.84	$3.43	$3.46
Total Capital	1,598	1,584	1,803	1,774	1,759	1,759	1,756	1,732	1,710	1,697	1,701
Total Debt	341	341	572	571	570	570	569	568	567	567	566
Total Long-Term Debt	167	166	0.00	571	570	570	569	568	567	567	566
Net Debt	-46	-28	1.37	14	58	102	122	169	227	236	299
Capital Expenditures (CapEx)	11	9.09	8.87	9.55	8.96	9.07	11	12	10	14	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	20	25	51	32	61	92	98	112	141	123	206
Debt-free Net Working Capital (DFNWC)	407	394	622	589	574	560	544	511	481	453	472
Net Working Capital (NWC)	232	220	50	589	574	560	544	511	481	453	472
Net Nonoperating Expense (NNE)	-1.11	-7.52	-3.76	-2.27	0.38	-1.98	-2.76	-1.26	-1.07	1.56	1.11
Net Nonoperating Obligations (NNO)	-46	-28	1.37	14	58	102	122	169	227	236	299
Total Depreciation and Amortization (D&A)	23	23	23	24	24	25	25	25	25	26	26
Debt-free, Cash-free Net Working Capital to Revenue	1.75%	2.24%	4.80%	2.94%	5.55%	8.00%	8.23%	9.05%	11.09%	9.49%	15.74%
Debt-free Net Working Capital to Revenue	35.81%	35.44%	58.42%	54.47%	52.02%	48.80%	45.90%	41.38%	37.94%	34.98%	36.08%
Net Working Capital to Revenue	20.44%	19.76%	4.67%	54.47%	52.02%	48.80%	45.90%	41.38%	37.94%	34.98%	36.08%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.15)	$0.34	$0.19	$0.08	($0.34)	($0.32)	$0.12	$0.08	($0.33)	($0.65)	$0.38
Adjusted Weighted Average Basic Shares Outstanding	46.60M	46.05M	46.15M	45.95M	45.73M	45.21M	45.33M	45.13M	44.89M	44.40M	44.44M
Adjusted Diluted Earnings per Share	($0.15)	$0.34	$0.19	$0.08	($0.34)	($0.32)	$0.12	$0.08	($0.33)	($0.62)	$0.37
Adjusted Weighted Average Diluted Shares Outstanding	46.60M	46.26M	46.43M	46.04M	45.73M	45.21M	45.60M	45.47M	44.89M	45.89M	45.82M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.84M	46.76M	46.32M	45.99M	45.92M	45.92M	45.47M	45.21M	45.08M	44.99M	44.65M
Normalized Net Operating Profit after Tax (NOPAT)	-8.13	8.32	4.87	2.26	-15	-16	2.79	5.42	-16	-27	18
Normalized NOPAT Margin	-3.02%	2.71%	1.73%	0.82%	-6.21%	-6.32%	0.93%	1.81%	-5.53%	-9.02%	5.14%
Pre Tax Income Margin	-3.53%	7.69%	4.12%	2.96%	-7.24%	-7.15%	2.47%	4.08%	-7.29%	-11.93%	4.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	924.40%	108.69%

Frequently Asked Questions About Omnicell's Financials

When does Omnicell's financial year end?

According to the most recent income statement we have on file, Omnicell's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Omnicell's net income changed over the last 10 years?

Omnicell's net income appears to be on a downward trend, with a most recent value of $12.53 million in 2024, falling from $30.52 million in 2014. The previous period was -$20.37 million in 2023. See where experts think Omnicell is headed by visiting Omnicell's forecast page.

What is Omnicell's operating income?

Omnicell's total operating income in 2024 was $337 thousand, based on the following breakdown:

Total Gross Profit: $471.00 million
Total Operating Expenses: $470.67 million

How has Omnicell revenue changed over the last 10 years?

Over the last 10 years, Omnicell's total revenue changed from $440.90 million in 2014 to $1.11 billion in 2024, a change of 152.3%.

How much debt does Omnicell have?

Omnicell's total liabilities were at $877.65 million at the end of 2024, a 15.4% decrease from 2023, and a 415.9% increase since 2014.

How much cash does Omnicell have?

In the past 10 years, Omnicell's cash and equivalents has ranged from $32.42 million in 2017 to $485.93 million in 2020, and is currently $369.20 million as of their latest financial filing in 2024.

How has Omnicell's book value per share changed over the last 10 years?

Over the last 10 years, Omnicell's book value per share changed from 10.96 in 2014 to 26.84 in 2024, a change of 145.0%.

Related Companies

This page (NASDAQ:OMCL) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Omnicell (OMCL) Financials

Frequently Asked Questions About Omnicell's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Omnicell (OMCL) Financials

Annual Income Statements for Omnicell

Quarterly Income Statements for Omnicell

Annual Cash Flow Statements for Omnicell

Quarterly Cash Flow Statements for Omnicell

Annual Balance Sheets for Omnicell

Quarterly Balance Sheets for Omnicell

Annual Metrics And Ratios for Omnicell

Quarterly Metrics And Ratios for Omnicell

Frequently Asked Questions About Omnicell's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools